Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Danaher Corporation

Share:
Related DHR
The Week Ahead: The Year's Biggest Biotech Conference, Host Of IPO Quiet Period Expirations, And Other Coming Catalysts
Henry Schein, Patterson Companies Downgraded On Amazon Fears
Legacy Private Trust Co. Buys iShares —…+ Year Treasury Bond ETF, SPDR Bloomberg Barclays ... (GuruFocus)

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Danaher Corporation (NYSE: DHR), and slightly raised its price target from $65.00 to $66.00.

Jefferies noted, “DHR pre-released 4Q12 organic revenue growth of >3%, well above our (+1%) and the consensus views, aided by a robust December showing. The stronger core revenue experience is expected to push 4Q12 EPS above the high-end of its prior range ($0.80 to $0.85). Our 2013 EPS forecast ($3.50) is unchanged, but our PT moves to $66 (from $65) on higher cash flow assumptions.”

Danaher Corporation closed on Tuesday at $57.68.

Latest Ratings for DHR

DateFirmActionFromTo
Oct 2017BairdMaintainsOutperform
Oct 2017Credit SuisseMaintainsOutperform
Oct 2017Morgan StanleyMaintainsOverweight

View More Analyst Ratings for DHR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (DHR)

View Comments and Join the Discussion!